We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 51

Bayer v. Canada
  • Gowling WLG
  • Canada
  • May 28 2009

The Court of Appeal dismissed Bayer’s appeal, thus affirming the refusal to list the patent on the Patent Register


Apotex v. Canada (Minister of Health)
  • Gowling WLG
  • Canada
  • May 28 2009

Apotex brought a judicial review of the Minister’s refusal to issue a NOC regarding its version of aspirin


Lundbeck v. Ratiopharm and Cobalt
  • Gowling WLG
  • Canada
  • May 28 2009

The Court of Appeal upheld the decision of the applications judge who struck the applications for judicial review


Eli Lilly v. Canada (Minister of Health)
  • Gowling WLG
  • Canada
  • May 28 2009

Eli Lilly had submitted patent lists seeking to add the newly issued patent at issue to the Patent Register with respect to several supplemental new drug submissions


Novopharm Limited v. Eli Lilly Canada Inc
  • Gowling WLG
  • Canada
  • May 28 2009

The Court of Appeal dismissed the appeal of the generic company from a decision of the motions judge refusing to dismiss the proceeding as a whole


Epicept v. Minister of Health; interlocutory motion for confidentiality; histamine
  • Gowling WLG
  • Canada
  • February 12 2010

Epicept has filed for a judicial review of the Minister's decision that its histamine dihydrochloride product is not an innovative drug and is thus not eligible for listing on the register of innovative drugs


Janssen-Ortho v. Novopharm; merits of 55.2 proceeding; methylphenidate
  • Gowling WLG
  • Canada
  • February 12 2010

The only issue in this proceeding was an allegation of non-infringement and the application for prohibition was dismissed


Mycogen v. Bayer and Monsanto; motion for summary judgment
  • Gowling WLG
  • Canada
  • February 12 2010

Bayer brought a motion for summary judgment on the basis that Monsanto had missed the time set out by the Commissioner under section 43 of the Patent Act to respond to the conflict proceeding


Sanofi v. Hospira, merits of a 55.2 proceeding
  • Gowling WLG
  • Canada
  • December 3 2009

The Court refused to grant an Order of Prohibition against Hospira regarding its docetaxel product


Biovail v. Apotex; merits of 55.2 proceeding; metformin
  • Gowling WLG
  • Canada
  • February 12 2010

The Court dismissed the application for prohibition